Akari Therapeutics, Statistics
Total Valuation
AKTX has a market cap or net worth of $7.40 million. The enterprise value is $7.06 million.
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026, before market open.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AKTX has 35.74 million shares outstanding. The number of shares has increased by 238.34% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 35.74M |
| Shares Change (YoY) | +238.34% |
| Shares Change (QoQ) | +3.78% |
| Owned by Insiders (%) | 32.87% |
| Owned by Institutions (%) | 3.85% |
| Float | 27.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of 0.10.
| Current Ratio | 0.19 |
| Quick Ratio | 0.16 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -37.61 |
Financial Efficiency
Return on equity (ROE) is -197.24% and return on invested capital (ROIC) is -85.65%.
| Return on Equity (ROE) | -197.24% |
| Return on Assets (ROA) | -34.20% |
| Return on Invested Capital (ROIC) | -85.65% |
| Return on Capital Employed (ROCE) | -44.16% |
| Weighted Average Cost of Capital (WACC) | 7.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.75M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.09M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.83% in the last 52 weeks. The beta is 0.34, so AKTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -80.83% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 33.30 |
| Average Volume (20 Days) | 301,472 |
Short Selling Information
The latest short interest is 209,369, so 0.67% of the outstanding shares have been sold short.
| Short Interest | 209,369 |
| Short Previous Month | 249,671 |
| Short % of Shares Out | 0.67% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.16M |
| Pretax Income | -16.86M |
| Net Income | -15.77M |
| EBITDA | -13.15M |
| EBIT | -13.16M |
| Earnings Per Share (EPS) | -$0.57 |
Full Income Statement Balance Sheet
The company has $2.48 million in cash and $2.22 million in debt, with a net cash position of $267,000 or $0.01 per share.
| Cash & Cash Equivalents | 2.48M |
| Total Debt | 2.22M |
| Net Cash | 267,000 |
| Net Cash Per Share | $0.01 |
| Equity (Book Value) | 22.69M |
| Book Value Per Share | 0.70 |
| Working Capital | -12.62M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -9.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.65M |
| FCF Per Share | -$0.27 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AKTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -238.34% |
| Shareholder Yield | -238.34% |
| Earnings Yield | -215.27% |
| FCF Yield | -131.72% |
Analyst Forecast
The average price target for AKTX is $2.53, which is 1,122.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.53 |
| Price Target Difference | 1,122.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 17, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 17, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |